Qualification: M.Sc. (Microbiology) & Ph.D (Biochemistry)

Dr. Shuvojit Moulik is a distinguished scientist with over 15 years of experience in cancer biology, with a particular focus on gynecological cancers. His research expertise encompasses cell signaling pathways, genetic mutations, and receptor biology, and he is proficient in a wide array of laboratory and analytical techniques. These include diagnostic assays, protein–protein interaction methods, and advanced microscopy, which he employs to uncover molecular mechanisms underlying cancer progression and therapeutic resistance. In addition to his scientific career, Dr. Moulik brings 14 years of interdisciplinary research and social engagement, bridging healthcare, disability rights, gender equality, and education for marginalized communities. He is the founder of the Civilian Welfare Foundation (CWF), through which he has initiated and led numerous projects that merge scientific insight with grassroots implementation. His work exemplifies a unique integration of biomedical research and social commitment, to advance both scientific innovation and societal well-being.

Thrust areas: 

• Affordable cancer diagnostics and screening (HRD, HPV)  
• Precision oncology and resistance biology  
• Integrative oncology adjuncts from traditional medicine  
• Palliative care and quality-of-life research using confocal imaging, 3D cultures, and phospho-proteomics.  
• Geo-clustered biorepositories for women’s cancers integrating clinical, molecular, and mental–physical data.
• Health equity for marginalized groups via point-of-care molecular diagnostics (HPV/HBV), trans-affirmative care, and PAR-driven delivery.  
• Neurohealth and disability: Parkinson’s mitochondrial probes, early neurodivergence biomarkers, arts- and sports-based therapeutics (women athletes).

Publications:

• Karmakar S, Dutta R, Moulik S Transdisciplinary Analysis of Human Papilloma Virus, Discover Medicine (Accepted Feb 2025)
• Moulik, S., Karmakar, S., Basu, A., Ali, M., & Chatterjee, A. (2024). Interdependency and differential expression of ERK1 and ERK2 in breast and melanoma cell lines. Journal of the Egyptian National Cancer Institute, 36(1), 27.
• Ganguly, O. M., & Moulik, S. (2023). Interactions of Mn complexes with DNA: the relevance of therapeutic applications towards cancer treatment. Dalton Transactions, 52(31), 10639-10656.
• Moulik S, Karmakar S, Basu A, Mukherjee S, Neeraja R, Chatterjee A. (2023) Studies of ERK1/2 with Respect to Tumor Aggressiveness in B16F10 Murine Melanoma Cells. International Journal for Multidisciplinary Research (IJFMR); 5 (1): 1-28.
• Basu A, Moulik S, Karmakar S. (2023) Bioaccumulation of different organic micropollutant in fishes and its toxicological stress impacts: A review. International Journal for Research in applied science & engineering and Technology (iJRASET). 11(2): 1549-1564
• Biswas, A., Pal, D., & Moulik, S. (2021). Managing the COVID-19 life: a study on the impact of the pandemic on athletes with intellectual and developmental disabilities (IDD) in West Bengal. Int Res J Multidiscip Scope, 2(3), 01-12.
• Biswas, A., Pal, D., & Moulik, S. (2021). Managing the COVID-19 life: a study on the impact of the pandemic on athletes with intellectual and developmental disabilities (IDD) in West Bengal. Int Res J Multidiscip Scope, 2(3), 01-12.
• Bhattacharyya, N., Mondal, S., Moulik, S., Paul, S., Bhattacharrya, S., Hazra, A. K., ... & Chatterjee, A. (2017). Effect of black tea polyphenol on cell-ECM interaction and MMP. American Journal of Plant Sciences, 8(04), 856.
• Sil, H., Moulik, S., Singha, I., Mandal, S. S., Biswas, J., & Chatterjee, A. (2015). Activation of matrix metalloproteinase 2 (MMP-2) in breast cancer progression. Journal of Tumor, 3(1), 292-299.
• Moulik S, Chatterjee A. (2014) Role of ERK1/2 in modulating MMP 2 and MMP9 with respect to tumour invasiveness in human cancer cell line MCF 7 and MDAMB231. Journal of Tumor.; 2(1):53-61
• Pal, S., Moulik, S., Dutta, A., & Chatterjee, A. (2014). Extracellular matrix protein laminin induces matrix metalloproteinase-9 in human breast cancer cell line mcf-7. Cancer microenvironment, 7(1), 71-78.
• Nanda, D. P., Sil, H., Moulik, S., Biswas, J., Mandal, S., & Chatterjee, A. (2013). Matrix metalloproteinase-9 as a potential tumor marker in breast cancer. Journal of Environmental Pathology, Toxicology and Oncology, 32(2).
• Ganguly, K. K., Pal, S., Moulik, S., & Chatterjee, A. (2013). Integrins and metastasis. Cell adhesion & migration, 7(3), 251-261.
• Pal, S., Kumar Ganguly, K., Moulik, S., & Chatterjee, A. (2012). Modulation of MMPs by cell surface integrin receptor α5β1. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 12(7), 726-732.
• Sil, H., Sen, T., Moulik, S., & Chatterjee, A. (2010). Black tea polyphenol (theaflavin) downregulates MMP-2 in human melanoma cell line A375 by involving multiple regulatory molecules. Journal of Environmental Pathology, Toxicology and Oncology, 29(1).
• Sen, T., Moulik, S., Dutta, A., Choudhury, P.R., Banerji, A., Das, S., Roy, M. and Chatterjee, A., (2009). Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life sciences, 84(7-8), pp.194-204.
• Moulik, S., Sen, T., Dutta, A., Banerji, A., Ghosh, C., Das, S., & Chatterjee, A. (2008). Phosphatidylinositol 3-kinase and NF-κB involved in epidermal growth factor-induced matrix metalloproteinase-9 expression. Journal of Cancer Molecules, 4(2), 55-60.
• Moulik, S., & Chatterjee, A. (2007). Vascular endothelial growth factor (VEGF) & tumour angiogenesis. Indian Journal of Medical Research, 125(6), 715-717.
• Adhikary, D., Brahmachary, A., Kar, A., Musaddi, D., & Moulik, S. (2020). Sports and Social Capital: A Qualitative Study on Women Athletes with Disabilities. discourse, 8, 9.

Manuscripts in Preparation: 

• Moulik S, Karmakar S, Basu A, Chatterjee A. Cytomegalovirus and Mental Health Paradigm World Cancer Journal (Submitted July 2024)
• Moulik S , Karmakar S, kar A, Mondol C, Mukhopadhya A. Ovarian cancer specific biobanking in eastern india Population. Biopreservation & biobanking journal. (Submitted July 2023)
• Moulik S, Bhattachrya A, Dutta R. Mental Health status in Trans-affirmative Healthcare in India